|
Tumor Growth In Breast Cancer And Angiosarcoma Inhibited By Novel Monoclonal Antibody
A monoclonal antibody targeting a protein known as SFPR2 has been shown by researchers at the University of North Carolina to inhibit tumor growth in pre-clinical models of breast cancer and angiosarcoma...
More... |
| All times are GMT -7. The time now is 04:48 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021